#SJSEnterprises
Have been writing about this one for quite sometime.
Thought of making a thread on it, just putting forward my views abt the co, & why I feel so confident about its growth prospects, despite the street not accepting it post listing.
Here it goes.
(1/n)
Co is the leading player in the Indian decorative aesthetics industry, serves to Automotives & Consumer Appliances industry.
No peer of the Co in domestic or overseas that could provide all variety of products that co have in their kitty, & kind of complexity co can handle.
(2/n)
SJS Enterprises caters to almost all categories of the Aesthetics, Below Table shows the comparison of some of the key players in Aesthetics.
SJS Enterprises is the only company to cover all categories, also it is the only listed company in the listed space with no peers
(3/n)
Co has the highest Ebitda margins amongst all its peers near 28 pct. While the total capacity of their plants is double the present utilization of close to 50 pct, so you will see operating leverage playing out in the coming quarters, as the Co grows
(4/n)
Around 58% topline comes from 2W, 17 pct from Passenger Vehicles & around 25% from Consumer Appliances
Also export share for the co is presently 16%, & Co is actively lukin to increase its share from exports by looking at inorganic opportunities in NA, EU & South East Asia
(5/n)
Global Aesthetic Industry (EU, UK & US) is 202.50 Billion Rupees as of 2019, which is also expected to grow 20% for next 5 years.
Co plans to take its export share to 25 pct by FY25.
Co has been strengthening its sales team, to acquire more biz overseas.
(6/n)
Co has an advantage of price competitive against global peers, while maintaining superior quality of its products.
Also the exports side, margins are even better compared to domestic, & co plans to use global acq, to get its products manufactured from Bangalore unit
(7/n)
to leverage on lower cost of production, being price competitive while providing superior quality.
Let's now understand the 100% OFS part of the IPO leading to disappointment among investors.
Everstone Captal had bought 51% stake in the co for 350 crore in 2015.
(8/n)
While they sold half their stake after almost 7 years through OFS, they wouldv got their cost of buying the stake almost 7 years back.
Street gave a thumbs down to the IPO mainly due to 100% OFS & no fresh issue, without looking at the prospects of the co:
(9/n)
>Co should grow 25% for next 4-5 years,with Ebitda margins 28-30 pct; while the industry degrew in FY21, SJS Enterprises showed growth in the same pandemic led period
>Capacity is double the current output, so further scope of margin improvement.
(10/n)
>Acquisitions across the Europe, US, South East Asia on the cards to further expand its reach in global markets.
All the above reasons make my conviction in the Co stronger day by day.
(11/n)
Hope the thread was helpful to those seeking more info abt the co. I have tried to cover all the points here.
#SJSEnterprises
Co is lookin for an acq in either South East Asia, Latin America Or Europe, co strategy is to acquire their clients, & produce the products frm B'lore unit, as it can produce much cheaper here n then export maintaining the superiority of the product.
Co targets to take the exports to 25 pct from current 16 pct, by FY25.
Also co expects for their subsidiary Exxotech( which currently has domestic presence only) to start exports for the chromium plated products to other countries as well.
>Exotech their recent acq grew 50 pct yoy with improvement in the margins
>Chrome plating order pipeline visibility is so strong for Exotech, Co will easily exhaust the existing capacity in year & half
(1/N)
>At current capacity of Exotech, can do a topline of 130 crore.
>Given the visibility in earnings, plan to expand the capacity to get a topline of 300 crore from chrome plated biz
>will do a capex of close to 100 crore over the next 18-24 months
(2/N)
>Under full capacity, the capex will yield ROCE of 20 pct
>Key thing to note, mgt is projecting revenue growth of 25 pct & bottom line growth of 30 pct for next 2 yrs, that too organically
(3/N)
#Windlas BioTech
We all have heard abt CDMO being a super theme, but majorly on international markets side.
Here I'll discuss a Co which is the one of Top 5 Domestic CDMO player, & the only listed player on Indian Bourses.
Do Like & Retweet, if you like the info
🧵🧵
(1/N)
Co is in the Top 5 Domestic Formulations CDMO in terms of Revenue.
Co operates in 3 verticals:
CDMO
Trade Generics &
Exports
(2/N)
While CDMO space is the one, where co focuses on products across pharmaceutical & nutraceutical segment.
Co mainly focuses on Chronic, SubChronic & Acute therapies.
Co provides CDMO services to 7 of the Top 10 (15
of top 20) Indian Pharma Formulations
Cos in FY22
(3/N)
INDIAN RAILWAYS plan to help farmers more than double their incomes from 30000-40000 ₹ per acre to 1 lakh per acre.
You read that right, INDIAN RAILWAYS.
HOW? ⬇
Do like & retweet the mini 🧵🧵
(1/6)
Indian Railways plan to hire farmers in arid regions of MP, Chhattisgarh & UP as maintenance operators of TSAs that act as electricity feeders to railway lines.
(2/6)
To start with, an initial capacity of 50MW will be offered to farmers in these states, following which 15GW substation capacity will be given to farmers across the country
Just an overview on the outlook the co, based on last earnings call
Do like & retweet if you liked the info.
🧵🧵
(1/N)
Co is into the business of manufacturing Non Ferrous Metals including Lead, Aluminum & Plastic using scraps.
Let's see the overall performance of the co in Q3.
(2/N)
Revenue in Q3 up 49 pct YoY wih Indian Biz contributing 63 pct, & rest by overseas Biz.
Increase in rev led by both Vol & Price. Vol growth of 14 pct shown by the co.
Value Added Products now 44 pct of total revenue
(3/N)
#KrsnaaDiagnostics
Hav written multiple times abt the co in the past.
Would like to cover in more detail via below thread to understand what's the outlook for this diagnostic play dominating in PPP space via
A Short 🧵
(1/N)
The best part abt their asset light biz is, they offer the diagnostics service 40-45 pct cheaper than other players like Dr Lal, Metropolis etc, & yet co has the best operating margins, & key thing to note, key players dont apply for these govt tenders due to low pricing
(2/N)
Where as Krsnaa has a strong hold in the domain, while their competitors are local players who apply in these govt tenders, while govt is now looking at giving tenders to more established players like Krsnaa, who can actually manage these services at affordable price
(3/N)
#HFCL
Thread on a Co which commands a strong hold in optical fiber & Optical fiber cables domestic as well as globally. & Co is moving towards product side of the biz around 5G.
Let's see what's all lined up for the co in future.
(1/n)
Co to deploy 425 crore for expansion of Fiber manufacturing capacities for both Optical Fiber & Optical Fiber cable.
Same to commission by June 2023.
Co has been approved as “Trusted Source” from National security council secretariat (NSCS)
(2/n)
Revenue mix of the co has moved from 26 pct product in 2020 to presently 42 pct from product side. Co aims to further increase the contribution from Product side, as it impacts the margins in a positive way & helping lowering the receivables
(3/n)